The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease

被引:1785
作者
Gleeson, Michael [1 ]
Bishop, Nicolette C. [1 ]
Stensel, David J. [1 ]
Lindley, Martin R. [1 ]
Mastana, Sarabjit S. [1 ]
Nimmo, Myra A. [1 ]
机构
[1] Univ Loughborough, Inflammat Exercise & Metab Res Grp, Sch Sport Exercise & Hlth Sci, Loughborough LE11 3TU, Leics, England
关键词
TYPE-2; DIABETES-MELLITUS; REGULATORY T-CELLS; C-REACTIVE PROTEIN; ADIPOSE-TISSUE; PHYSICAL-ACTIVITY; RECEPTOR EXPRESSION; MACROPHAGE INFILTRATION; CARDIOVASCULAR-DISEASE; CD14+CD16+ MONOCYTES; ENDOCRINE ORGAN;
D O I
10.1038/nri3041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Regular exercise reduces the risk of chronic metabolic and cardiorespiratory diseases, in part because exercise exerts anti-inflammatory effects. However, these effects are also likely to be responsible for the suppressed immunity that makes elite athletes more susceptible to infections. The anti-inflammatory effects of regular exercise may be mediated via both a reduction in visceral fat mass (with a subsequent decreased release of adipokines) and the induction of an anti-inflammatory environment with each bout of exercise. In this Review, we focus on the known mechanisms by which exercise-both acute and chronic-exerts its anti-inflammatory effects, and we discuss the implications of these effects for the prevention and treatment of disease.
引用
收藏
页码:607 / 615
页数:9
相关论文
共 113 条
[1]
Walking and dementia in physically capable elderly men [J].
Abbott, RD ;
White, LR ;
Ross, GW ;
Masaki, KH ;
Curb, JD ;
Petrovitch, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (12) :1447-1453
[2]
[Anonymous], 2011, OBESITY, DOI DOI 10.1038/oby.2010.123
[3]
Baeten D, 2000, ARTHRITIS RHEUM, V43, P1233, DOI 10.1002/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO
[4]
2-9
[5]
Effect of an Intensive Exercise Intervention Strategy on Modifiable Cardiovascular Risk Factors in Subjects With Type 2 Diabetes Mellitus A Randomized Controlled Trial: The Italian Diabetes and Exercise Study (IDES) [J].
Balducci, Stefano ;
Zanuso, Silvano ;
Nicolucci, Antonio ;
De Feo, Pierpaolo ;
Cavallo, Stefano ;
Cardelli, Patrizia ;
Fallucca, Sara ;
Alessi, Elena ;
Fallucca, Francesco ;
Pugliese, Giuseppe ;
Falluca, Francesco ;
Pugliese, Giuseppe ;
Missori, Serena ;
Ribaudo, Maria Cristina ;
Alessi, Elena ;
Strollo, Felice ;
More, Massimo ;
Alimonti, Pietro ;
Di Biase, Nicolina ;
Lasaracina, Filomena ;
Santantonio, Graziano ;
Cruciani, Laura ;
Manunta, Mario ;
Di Mauro, Maurizio ;
Sesti, Giorgio ;
Irace, Concetta ;
Puccio, Luigi ;
Cignarelli, Mauro ;
Nicastro, Vincenzo ;
Piemontese, Sabrina ;
Corigliano, Gerardo ;
Rossi, Ernesto ;
Corigliano, Marco ;
Fatone, Cri ;
Baggiore, Cristiana ;
Russo, Roberto ;
Boemi, Massimo ;
Lanari, Luigi ;
Valentini, Umberto ;
Girelli, Angela ;
Di Bartolo, Paolo ;
Pellicano, Francesca ;
Mazzuca, Paolo ;
Manicardi, Enrica ;
Bruno, Alberto ;
Sambataro, Maria ;
Pontiroli, Antonio ;
Laneri, Marco ;
Boggio, Anna ;
Zagari, Nunzio .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (20) :1794-1803
[6]
"Sick Fat," Metabolic Disease, and Atherosclerosis [J].
Bays, Harold E. .
AMERICAN JOURNAL OF MEDICINE, 2009, 122 (01) :S26-S37
[7]
The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF [J].
Belge, KU ;
Dayyani, F ;
Horelt, A ;
Siedlar, M ;
Frankenberger, M ;
Frankenberger, B ;
Espevik, T ;
Ziegler-Heitbrock, L .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3536-3542
[8]
Two-month effects of individualized exercise training with or without caloric restriction on plasma adipocytokine levels in obese female adolescents [J].
Ben Ounis, O. ;
Elloumi, M. ;
Lac, G. ;
Makni, E. ;
Van Praagh, E. ;
Zouhal, H. ;
Tabka, Z. ;
Amri, M. .
ANNALES D ENDOCRINOLOGIE, 2009, 70 (04) :235-241
[9]
Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis [J].
Bergmann, M ;
Gornikiewicz, A ;
Sautner, T ;
Waldmann, E ;
Weber, T ;
Mittlböck, M ;
Roth, E ;
Függer, R .
SHOCK, 1999, 12 (06) :421-427
[10]
Bermon S, 2007, EXERC IMMUNOL REV, V13, P6